JP6581758B2 - 幹細胞及びそのデータを獲得する方法 - Google Patents

幹細胞及びそのデータを獲得する方法 Download PDF

Info

Publication number
JP6581758B2
JP6581758B2 JP2014127875A JP2014127875A JP6581758B2 JP 6581758 B2 JP6581758 B2 JP 6581758B2 JP 2014127875 A JP2014127875 A JP 2014127875A JP 2014127875 A JP2014127875 A JP 2014127875A JP 6581758 B2 JP6581758 B2 JP 6581758B2
Authority
JP
Japan
Prior art keywords
cells
stem cells
sample
data
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014127875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015006183A5 (enExample
JP2015006183A (ja
Inventor
ワン ジェイムズ
ワン ジェイムズ
ケイ チェン スティーブ
ケイ チェン スティーブ
リン モウ−シウン
リン モウ−シウン
イェン，ユン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stembios Technologies Inc
Original Assignee
Stembios Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stembios Technologies Inc filed Critical Stembios Technologies Inc
Publication of JP2015006183A publication Critical patent/JP2015006183A/ja
Publication of JP2015006183A5 publication Critical patent/JP2015006183A5/ja
Application granted granted Critical
Publication of JP6581758B2 publication Critical patent/JP6581758B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Ecology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2014127875A 2013-06-24 2014-06-23 幹細胞及びそのデータを獲得する方法 Active JP6581758B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361838359P 2013-06-24 2013-06-24
US61/838,359 2013-06-24
US201361912563P 2013-12-06 2013-12-06
US61/912,563 2013-12-06

Publications (3)

Publication Number Publication Date
JP2015006183A JP2015006183A (ja) 2015-01-15
JP2015006183A5 JP2015006183A5 (enExample) 2017-08-03
JP6581758B2 true JP6581758B2 (ja) 2019-09-25

Family

ID=51947635

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014127875A Active JP6581758B2 (ja) 2013-06-24 2014-06-23 幹細胞及びそのデータを獲得する方法
JP2014127876A Pending JP2015006184A (ja) 2013-06-24 2014-06-23 幹細胞及びそのデータを獲得する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014127876A Pending JP2015006184A (ja) 2013-06-24 2014-06-23 幹細胞及びそのデータを獲得する方法

Country Status (5)

Country Link
US (3) US20140377760A1 (enExample)
EP (2) EP2818545A1 (enExample)
JP (2) JP6581758B2 (enExample)
CN (2) CN104232567A (enExample)
TW (2) TW201920951A (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
TWI571513B (zh) 2011-09-28 2017-02-21 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
JP6495174B2 (ja) 2012-12-06 2019-04-03 ステムバイオス テクノロジーズ，インコーポレイテッド Ｌｇｒ５＋体性幹細胞
EP2746770A1 (en) 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US20140377760A1 (en) * 2013-06-24 2014-12-25 StemBios Technologies, Inc. Method for increasing number of stem cells in human or animal bodies
WO2016081553A1 (en) * 2014-11-19 2016-05-26 StemBios Technologies, Inc. Somatic stem cells for treating bone defects
CN105687245A (zh) * 2014-12-13 2016-06-22 干细胞生物科技公司 制备注射液的方法
US20160271185A1 (en) * 2015-03-16 2016-09-22 StemBios Technologies, Inc. Method of preparing solution containing stem cells
EP3328400A4 (en) * 2015-07-28 2019-03-27 Stembios Technologies, Inc. COMPOSITION AND METHOD FOR INHIBITING HISTONATE ACETYLASE
US10221385B2 (en) * 2016-05-27 2019-03-05 Fenwal, Inc. Cell processing system and method with post-separation cell count control
EP3270307B1 (en) * 2016-07-13 2022-06-22 Fenwal, Inc. Cell processing system and method with centralized data management, monitoring and/or control
WO2018144981A1 (en) * 2017-02-06 2018-08-09 StemBios Technologies, Inc. Use of somatic stem cells for increasing autophagy
CN109234162A (zh) * 2018-10-22 2019-01-18 广东省心血管病研究所 一种干细胞自动培养系统
MA55471A (fr) 2019-12-27 2022-02-09 Beckman Coulter Inc Instrument de préparation d'échantillons
US20230235288A1 (en) * 2020-06-23 2023-07-27 Tithon Biotech, Inc. Peripheral blood derived small pluripotent cells
JP7770121B2 (ja) * 2021-06-30 2025-11-14 ポーラ化成工業株式会社 ヒアルロン酸受容体発現促進剤、これを含む皮膚外用剤並びに高分子ヒアルロン酸の保持効率向上方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955257A (en) * 1997-10-21 1999-09-21 Regents Of The University Of Minnesota Infusible grade short-term cell storage medium for mononuclear cells
US20020142462A1 (en) * 1997-11-26 2002-10-03 Ildstad Suzanne T. Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
AU1705599A (en) * 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US7112576B1 (en) * 1999-12-10 2006-09-26 Regents Of The University Of Minnesota Compositions and methods for cryopreservation of peripheral blood lymphocytes
JP2003073300A (ja) * 2001-09-03 2003-03-12 Morinaga Milk Ind Co Ltd 造血前駆細胞動員増強剤
JP3968383B2 (ja) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防
CA2640087A1 (en) * 2006-01-25 2007-08-02 Mount Sinai School Of Medicine Methods and compositions for modulating the mobilization of stem cells
CN1945326A (zh) * 2006-10-13 2007-04-11 江西特康科技有限公司 基于视觉形态的五分类全血细胞分析方法
US20090104160A1 (en) * 2007-02-01 2009-04-23 Moraga Biotechnology Corporation Mobilization of Stem Cells After Trauma and Methods Therefor
EP2022848A1 (en) * 2007-08-10 2009-02-11 Hubrecht Institut A method for identifying, expanding, and removing adult stem cells and cancer stem cells
TW201017149A (en) * 2008-08-06 2010-05-01 Invitrox Inc Use of focused light scattering techniques in biological applications
CA2835313A1 (en) * 2010-05-07 2011-11-10 Institut De Recherches Cliniques De Montreal Gfi1b modulation and uses thereof
EP3153173A1 (en) * 2010-06-28 2017-04-12 Stemtech International, Inc. Methods and compositions for enhancing stem cell mobilization
EP3569696A1 (en) * 2010-08-04 2019-11-20 Stembios Technologies, Inc. Somatic stem cells
US20120270314A1 (en) * 2011-04-19 2012-10-25 Buddhist Tzu Chi General Hospital Non-tumorigenic expansion of pluripotent stem cells
TWI571513B (zh) * 2011-09-28 2017-02-21 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
US20140377760A1 (en) * 2013-06-24 2014-12-25 StemBios Technologies, Inc. Method for increasing number of stem cells in human or animal bodies

Also Published As

Publication number Publication date
CN104232580A (zh) 2014-12-24
JP2015006184A (ja) 2015-01-15
US20140377760A1 (en) 2014-12-25
EP2818544A1 (en) 2014-12-31
TW201920951A (zh) 2019-06-01
CN104232567A (zh) 2014-12-24
US20190257819A1 (en) 2019-08-22
EP2818545A1 (en) 2014-12-31
TWI640884B (zh) 2018-11-11
TW201502832A (zh) 2015-01-16
US20180024122A1 (en) 2018-01-25
JP2015006183A (ja) 2015-01-15

Similar Documents

Publication Publication Date Title
JP6581758B2 (ja) 幹細胞及びそのデータを獲得する方法
TWI670496B (zh) 利用幹細胞資料評估行為效果的方法
US20190105346A1 (en) Method of preparing injection solution
US20190350986A1 (en) Method of preparing solution containing stem cells
TW201707713A (zh) 用於抑制組蛋白去乙醯酶之組成物及方法
TW201819623A (zh) 用於降低膽紅素位準之組成物及方法
TW201821089A (zh) 用於增加介白素-1受體拮抗物之位準的組成物及方法
TW201829769A (zh) 體幹細胞用於降低il-6位準的用途
TW201821088A (zh) 用於降低肝細胞生長因子之位準的組成物及方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170621

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170621

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180515

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180815

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181009

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190621

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190806

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190902

R150 Certificate of patent or registration of utility model

Ref document number: 6581758

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250